Valent Biosciences Corporation

Ayyappan Nair

Zhengyu Huang

Gregory D Venburg

Benjamin A Belkind

Yueh Wang

Robert Scott Fassel

John Lopez

Terry A Benson

Samun Dahod

Yong-Ki Kim

Ashish Harihar Dave

Regina Adams

The present invention generally relates to concentrated natamycin suspension formulations for inhibition of fungal growth. Specifically, the present invention relates to stable suspension concentrate formulations comprising from about 25% to about 48% w/w natamycin, from about 0.1% to about 10% w/w of an anionic surfactant selected from the group consisting of polyelectrolyte polymers, modified styrene acrylic polymers, dioctyl sodium sulfosuccinates, sodium salts of naphthalene sulfonates, and combinations thereof, and water. The formulations of the present invention contain natamycin as particles which are on average less than 11 microns in diameter and the formulations have a viscosity of less than 1400 centipoise at 21 degrees Celsius.

Concentrated natamycin suspension formulations

A novel bacterial strain of, VBTS 2528, is described. This strain comprises genes encoding Cry1Ac, Cry 1Ca, and Cry2Aa endotoxin proteins. The invention further relates to an insecticidal composition comprising a mixture of VBTS 2528 and to methods for controlling insect pests utilizing VBTS 2528.

[object Object]

The invention relates to low VOC plant growth regulator compositions comprising less than about 25% of volatile organic compounds (VOCs). The compositions comprise forchlorfenuron (CPPU). Also provided are methods of using the compositions.

Low VOC and stable plant growth regulator liquid and granule compositions

Growing community of inventors

Des Plaines, IL, United States of America

Ayyappan Nair